Skip to main content
. 2016 Feb 25;7(13):17074–17086. doi: 10.18632/oncotarget.7717

Figure 3. Kaplan–Meier survival analysis of CRMP4 expression in patients with gastric cancer.

Figure 3

Kaplan–Meier analysis of cumulative survival according to low expression (102 patients) and high expression (63 patients) of CRMP4 determined by IHC in patients with gastric cancer. P values are based on the log-rank test. Patients with high CRMP4 expression had a worse survival than those with low expression of CRMP4 (P < 0.001).